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Pharmacists can assist patients in managing their blood pressure
levels. We assessed whether adherence to blood pressure medica-
tion improved among people who used community pharmacies in
rural Montana after pharmacists initiated consultations and distrib-
uted educational materials developed for the Million Hearts Initiat-
ive’s “Team Up. Pressure Down.” (TUPD) program.
Methods
From 2014 to 2016, the Cardiovascular Health Program at the
Montana Department of Public Health and Human Services con-
ducted a statewide project to evaluate an intervention for adher-
ence to blood pressure medication administered through com-
munity pharmacies. After the year 1 pilot, we redesigned the pro-
gram for year 2 and year 3 and measured the percentage of parti-
cipating patients who adhered to blood pressure medication. We
also conducted a statewide survey to assess pharmacy characterist-
ics,  computer-system capabilities,  and types of consulting ser-
vices provided by pharmacists.
Results
Twenty-five community pharmacies completed Montana’s TUPD
program: 8 pharmacies in the pilot year, 11 pharmacies in year 2,
and 6 pharmacies in year 3. For year 2 and year 3 combined, the
percentage of participating patients who achieved blood pressure
medication adherence improved preintervention to postinterven-
tion from 73% to 89%, and adherence improved in 15 of the 17
pharmacies. The pilot pharmacies identified 3 major barriers to
project success: patient buy-in, staff burden in implementing the
project, and funding. In the statewide assessment, TUPD-funded
pharmacies were significantly more likely than non-TUPD–fun-
ded pharmacies to provide prescription synchronization and med-
ication management with feedback to the patient’s physician.
Conclusion
Community pharmacies in rural areas can effectively use brief
consultations and standard educational materials to improve adher-
ence to blood pressure medication.
Introduction
High blood pressure is a controllable risk factor for cardiovascu-
lar diseases (eg, heart disease, stroke) (1). However, patients with
hypertension often find it challenging to manage their condition.
Barriers to management may include problems with medication
adherence, not understanding the seriousness of the condition, or
difficulty making lifestyle changes. Community pharmacists can
extend the reach of health care providers and assist patients in con-
trolling their hypertension. With ready and consistent access to pa-
tients who refill prescriptions monthly, pharmacists are in a posi-
tion to establish an ongoing relationship with their patients.
A meta-analysis of 7 randomized controlled trials showed that ad-
herence to blood pressure medication increased more in the phar-
macist-led interventions than in the control groups (2). In the 6
studies that provided quantitative data, adherence in the interven-
tion groups increased from 56% (203 of 360 participants) to 68%
(246 of 360 participants);  in the control groups,  adherence in-
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creased from 59% (190 of 320 participants) to 61% (195 of 320
participants).  Another  meta-analysis  found that  7  of  16  phar-
macist interventions significantly increased medication adherence
(3); the difference between adherence in the intervention groups
compared with the control groups ranged from 8 to 58 percentage
points.
Pharmacy-based interventions  are  also  effective  in  improving
medication adherence among people in racial/ethnic minority pop-
ulations (4,5). We found no studies of pharmacy interventions to
improve adherence to blood pressure medication in rural areas.
Because of a shortage of primary care providers in rural areas (6),
pharmacies in rural areas could play a larger role in improving
medication  adherence  than  pharmacies  in  urban  areas.  Phar-
macists can help identify and overcome barriers (eg, financial dif-
ficulties, side effects) that health care providers may not detect
during patient visits, which often are infrequent. Pharmacies also
can assist patients in managing their blood pressure levels (3,7).
Only 2 interventions that we reviewed (4,8) provided patients with
pharmacist consultations and educational materials on blood pres-
sure medication adherence. However, these interventions did not
rigorously assess the usefulness of the educational materials.
We evaluated whether patients’ adherence to blood pressure med-
ication improved in rural Montana when we used pharmacy con-
sultations in combination with educational materials that were de-
veloped for the Million Hearts Initiative’s “Team Up. Pressure
Down.” (TUPD) and were designed for community pharmacists
and their patients (9). Our secondary objective was to describe
pharmacy characteristics, computer-system capabilities, and types
of  consulting  services  provided  by  pharmacists  throughout
Montana.
Methods
This  study  consisted  of  2  components:  1)  a  3-year  (February
2014–June 2016) intervention to improve adherence to blood pres-
sure medication among people using community pharmacies in
rural  Montana  and  2)  a  statewide  assessment  (November
2015–February 2016) of pharmacy characteristics, computer-sys-
tem capabilities, and types of consulting services provided.
Montana is the fourth largest state geographically but is ranked
48th in the United States for population density, with only 6.8 per-
sons per square mile (10). Much of the state is classified as an area
with a shortage of health care professionals or as a medically un-
derserved area (11). According to rural–urban commuting area
codes, less than 20% of Montana’s counties had census tracts with
a classification of “metropolitan area core” or “metropolitan area
high commuting” (12). For the TUPD project, most participating
pharmacies were in counties outside these metropolitan areas (13).
Community pharmacy intervention
In 2014, the Montana Cardiovascular Health (CVH) Program at
the Department of Public Health and Human Services (DPHHS)
initiated a project with 9 community pharmacies in Montana to
conduct and evaluate a blood pressure medication adherence inter-
vention.  However,  one funded pharmacy did not  complete the
project because of problems with business structure and staffing.
The project used an implementation study design and 3 cohorts
(Box 1). The project was supported by the Centers for Disease
Control and Prevention (CDC) (14). The Montana DPHHS did not
require institutional review board approval because pharmacies
submitted only de-identified aggregate data.
Box 1. Timeline for Team Up. Pressure Down. (TUPD) Blood Pressure
Medication Adherence Project in Community Pharmacies, Montana,
2014–2016
February–June 2014: Pilot project completed with 8 pharmacies
June–August 2014: Formative evaluation
August 2014–June 2015: Year 2 cohort — 11 pharmacies
August 2015–June 2016: Year 3 cohort — 6 pharmacies
November 2015–February 2016: Community pharmacy assessment
The  University  of  Montana’s  Skaggs  School  of  Pharmacy
provided a list of 258 community pharmacies in Montana. A com-
munity pharmacy is designated by the Montana Department of
Labor and Industry as a pharmacy that serves customers in a retail
setting, such as a pharmacy chain or an independent pharmacy,
rather than in an institutional setting, such as a hospital. To recruit
pharmacies for the pilot project, the CVH Program mailed an ap-
plication to all 258 community pharmacies listed, and the Montana
Pharmacy Association emailed the announcement to its members.
In  addit ion,  Montana’s  Medicare  Quali ty  Innovation
Network–Quality Improvement Organization helped recruit phar-
macies and disseminate project materials.
Montana DPHHS staff members reviewed 9 applications for the
pilot year. The criteria for funding included providing an estimate
of the number of patients in the pharmacy who were taking blood
pressure medication and the number of patients to be tracked and
providing an adequate description of a project plan, including se-
lecting, tracking, and following up with patients. Applicants also
were required to describe components that could be continued by
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the pharmacy without external funding. In the pilot year, all 9 ap-
plicants met the application criteria and were funded. Using a sim-
ilar application and notification process, we funded 2 more co-
horts: 11 pharmacies in year 2 and 7 pharmacies in year 3 (one of
which did not complete the project because of a staffing shortage).
Pilot project
Each pilot pharmacy was required to recruit at least 25 patients.
Participants were required to meet the following minimum criteria:
1) being an adult aged 18 years or older, 2) having had at least one
pharmaceutical claim during the previous calendar year (ie, an act-
ive pharmacy patient), and 3) having had at least one current pre-
scription for a medication to lower blood pressure. Pharmacies
were permitted to customize approaches for identifying and re-
cruiting participants (eg, letters, direct contact).
As part of the project, pharmacies conducted a brief consultation
with each participating patient. During the consultation, the phar-
macist discussed medication management and changes in lifestyle
behavior to help improve the patient’s medication adherence and
blood pressure control. We asked the pharmacies to disseminate
TUPD’s patient-education materials and information on the Diet-
ary Approaches to Stop Hypertension (DASH) program (15) and
to refer smoking patients to the Montana Tobacco Quitline (16).
TUPD’s patient-education materials included a blood pressure
journal, a medication tracker wallet card, and a medication re-
minder handout. Additionally, participants received a postcard
with information on steps to control blood pressure and a place to
list pharmacy and prescription information. TUPD’s pharmacist
materials included a pocket discussion guide, a drug-adherence
work-up tool (to identify and address patient barriers to taking
medication), a blood pressure guide (a quick reference on taking
blood pressures manually and interpreting blood pressure read-
ings), and a pharmacy poster.
During the pilot program, pharmacies measured medication adher-
ence by 1) calculating the number of days of refill  for a blood
pressure medication for each participating patient or 2) using an-
other standard method, such as calculating the percentage of parti-
cipating patients who achieved blood pressure medication adher-
ence, measured as the proportion of days covered (PDC) by pre-
scription claims as 80% or greater (based on prescription fill date
and days of supply). We did not require pharmacies to adhere to a
particular  method of  calculating adherence.  Some pharmacies
electronically tracked prescription fill dates, and others used an
Excel (Microsoft Corp) spreadsheet.
Although the pilot project was designed initially to be implemen-
ted during a 10-month period, it  was implemented during a 4-
month period because of a delay in budget approval. After the
conclusion of the pilot program, we obtained feedback from the
pilot pharmacies and modified the intervention for year 2 and year
3. We also sought federal guidance on a standard definition of
medication adherence (17) and requested additional funding so
that we could recruit more pharmacies and increase the funding
award to pharmacies as an incentive for them to participate.
Year 2 and year 3
In year 2 and year 3, in addition to other program improvements
(Box 2), we required pharmacies to use a standardized definition
for medication adherence (PDC ≥80%). We received additional
funding, which allowed us to double the funding award to pharma-
cies. We shared lessons learned from the pilot pharmacies with the
new pharmacies, emphasized project expectations, and provided
additional technical assistance.
Box 2. Components of Team Up. Pressure Down. (TUPD) in Year 2 and Year
3, Based on Feedback From Pilot Year, Montana, 2014–2016
• Standardized the definition of medication adherence (17)
• Expanded project time frame from 4 months to 10 months
• Increased the minimum number of patients required to participate from
25 to 35 (year 3 only)
• Doubled the funding award to pharmacies as an incentive for partici-
pation
• Offered 2 training options for pharmacists: a home-study blood pres-
sure curriculum and a 1-day hands-on hypertension workshop on accurate
blood pressure measurements, current guidelines, lifestyle changes, and
medication management
• Provided additional resources to each participating pharmacy: blood
pressure cuffs for on-site use and 7-day pill boxes for participating patients
• Provided a sample letter that pharmacists could send to health care pro-
viders informing them of their patients’ participation in the project
• Provided a sample press release that pharmacists could send to the loc-
al news media to inform their community of the project
• Created an Excel (Microsoft Corp) tracking program for such patient in-
terventions as medication therapy management and lifestyle counseling
• Organized a conference call in which a previously participating phar-
macist oriented newly participating pharmacists
• Hired a consulting pharmacist, who owns a community pharmacy, to
provide technical assistance and engage pharmacists on a peer-to-peer
basis
Data collection
The CVH Program collected data from reports filed one month
after  the  project  began and final  reports.  Pre-intervention and
postintervention data were collected on medication adherence at
the start and end of each of the 3 project periods. The CVH Pro-
gram developed a final report template that community pharma-
cies completed at the end of each project period. The final report
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gave information on barriers, lessons learned, sustainable compon-
ents,  and suggestions  for  improvement.  The final  reports  also
provided data on types of counseling provided and pharmacists’
perceptions of the usefulness of TUPD materials and resources.
Lastly, the final report provided aggregate data on the percentage
(numerator and denominator) of participating patients who ad-
hered to their blood pressure medication schedule. In addition, for
year 2 and year 3, the CVH Program periodically requested inter-
im feedback from the participating pharmacies on progress made
and barriers encountered. A consulting pharmacist reviewed the
feedback and made suggestions to address barriers as part of his
technical assistance.
Statewide pharmacy assessment
From November 2015 through February 2016, the CVH Program
conducted a statewide assessment of community pharmacies to
collect data required by CDC to measure grant performance. In
October 2015, the CVH Program and a community pharmacist re-
viewed and revised a survey instrument that the program had de-
signed and used in a statewide assessment in 2013. In November
2015, the Montana Department of Labor and Industry provided a
list of licensed community pharmacies. We merged this list and
the TUPD recruitment list from the Skaggs School of Pharmacy
and eliminated duplicate pharmacies by matching license number,
business name, and city, which yielded 259 community pharma-
cies.  The survey,  which was mailed,  collected information on
pharmacy characteristics (the number of pharmacists and phar-
macy technicians); computer-system capabilities (acceptance of
electronic prescriptions from outside health care facilities, auto-
matic refills on certain maintenance medications, automated refill
reminders for blood pressure medication); provision of prescrip-
tion synchronization (the process of aligning refill dates for all of a
patient’s multiple prescriptions); reimbursement of medication
therapy management from Mirixa or OutcomesMTM, 2 leading
vendors of medication therapy management services in Montana;
and the  types  of  consulting services  provided by pharmacists.
Medication therapy management is a service provided by phar-
macists to optimize drug therapy and improve health outcomes.
Data analysis
For year 2 and year 3 of the intervention, we aggregated the data
from the final reports for medication adherence (percentage of par-
ticipants with PDC ≥80% and total number of participants) from
each  pharmacy.  Details  on  the  calculation  of  PDC,  including
definition of terms, unit of analysis, and determination of numerat-
ors and denominators, are available elsewhere (17). To generate an
overall rate, we aggregated the data on medication adherence by
year. The pilot sites were excluded from the medication adher-
ence analysis because they were not required to use a standard
definition for medication adherence.
For the community pharmacy assessment, we analyzed data using
IBM SPSS Statistics version 21 (IBM Corporation). We used χ2
tests to assess any differences in pharmacy and consultation ser-
vices offered by pharmacists, such as consultation on blood pres-
sure medication adherence, between pharmacies funded by TUPD
and pharmacies not funded by TUPD. We also used the nonpara-
metric  Mann–Whitney U test  to  compare differences  between
pharmacies  funded  by  TUPD  and  pharmacies  not  funded  by
TUPD in the number of pharmacists and pharmacy technicians. A
P value of < .05 was considered significant.
Results
Twenty-five community pharmacies completed Montana’s TUPD
project: 8 in the pilot year, 11 in year 2, and 6 in year 3. All 25
pharmacies submitted a final report. For year 2 and year 3 com-
bined (17 pharmacies), 534 patients completed the TUPD project,
with 360 in year 2 and 174 in year 3; the aggregated percentage of
participating patients who achieved blood pressure medication ad-
herence increased from 73% pre-intervention to 89% postinterven-
tion (Figure). Blood pressure medication adherence improved in
15 of the 17 community pharmacies in year 2 and year 3.
Figure.  Percentage  of  patients  who achieved blood  pressure  medication
adherence (proportion of days covered [PDC] by prescription claims ≥80%)
pre-intervention  and  postintervention  among  community  pharmacies
participating in  TUPD (N = 17)  in  year  2 and year  3,  by  year  and overall,
Montana, July 2014–June 2016. Community pharmacies during the pilot year
were excluded from this analysis because they were not required to use a
standardized definition for medication adherence. Abbreviation: TUPD, Team
Up. Pressure Down.
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Feedback from pharmacists
The pilot pharmacies identified 3 major barriers to project success:
patient buy-in, staff burden in implementing the project, and fund-
ing. A lack of awareness of the importance of controlling blood
pressure, a lack of willingness or interest in project participation,
and lack of recognition of the benefits of participation were major
obstacles among patients. Staff burden was the most common bar-
rier reported by the pharmacies. Adding another program to a busy
schedule was difficult. A lack of time limited the ability of the
pharmacists to provide customer service and pharmacy counsel-
ing beyond the core task of dispensing medication. In the pilot
project, the pharmacists’ suggestions for enhancing the project in-
cluded developing a template for tracking patients, a notification
letter to health care providers, and a checklist of topics to discuss
with patients. These resources were added in year 2 and year 3.
Other recommendations (a wallet card to log blood pressure val-
ues and a survey to obtain patient feedback) will be added in year
4.
Feedback from year 2 and year 3 indicated that involving the en-
tire pharmacy team in the project helped reduce the burden of
work on the pharmacists. For example, one pharmacy created a
system in which TUPD materials were attached to a patient’s med-
ication refill. When the patient picked up the refill, the pharmacy
technician notified the patient that the pharmacist wanted to speak
with him or her. Another pharmacy involved the pharmacy techni-
cians in using an alert system (tracking sheet) when a study pa-
tient was in the pharmacy so that pharmacists could provide con-
sultations.
TUPD-funded pharmacies reported that TUPD materials and re-
sources were useful. Although all participating pharmacies repor-
ted distributing TUPD materials, pharmacists reported only 75%
of project participants received these materials because some pa-
tients refused them. Pharmacists noted that the wallet card and
journal  were helpful  and of  interest  to  patients,  although they
noted that some of the materials could be written more concisely.
Additionally, 21 pharmacies reported their pharmacists provided
lifestyle counseling and medication therapy management to their
patients with hypertension.
The pharmacists noted that most of their patients appreciated the
extra attention they received during the consultations. Pharmacists
adjusted the length of the consultation according to the interest
level and needs of each patient. Three pharmacists suggested that
the TUPD project may be most suitable for patients with a new
diagnosis of hypertension because patients with long-term hyper-
tension had already found ways to manage their condition. One
pharmacy lost  many project  participants  because  of  the  parti-
cipants’ transient employment (oil workers). In addition, 13 phar-
macies noted difficulty tracking patients (eg, patient used mail-or-
der or 90-day prescriptions, transferred pharmacies, died, was hos-
pitalized, or moved). Three pharmacies found opportunities to col-
laborate with patients’ providers to improve blood pressure con-
trol.
Twenty pharmacies reported plans to sustain at least one project
component to foster medication adherence (eg, measuring blood
pressure  on-site,  offering  counseling  or  medication  reviews,
providing blood pressure information materials,  synchronizing
medication, creating a system of automatic refills).
Statewide pharmacy assessment
The response rate for the community pharmacy assessment con-
ducted  was  46% (120  of  259).  The  average  number  of  phar-
macists per pharmacy in Montana was fewer than 3 (Table). We
found no significant differences between TUPD-funded pharma-
cies and non-TUPD–funded pharmacies in the number of phar-
macy staff members or pharmacy services related to whether or
not  automatic  refills  or  refill  reminders  are  provided  (Table).
TUPD-funded pharmacies  were significantly  more likely than
non-TUPD–funded pharmacies to provide prescription synchron-
ization and medication management with feedback to the patient’s
physician. TUPD-funded pharmacies also were more likely than
nonfunded pharmacies to report that pharmacists were reimbursed
for formal medication therapy management from Mirixa or Out-
comesMTM.
Discussion
Our findings indicate that it is feasible for community pharmacies
in rural areas to provide their patients with brief consultations and
TUPD educational materials on how to improve blood pressure
medication adherence. Our results are similar to those reported in
other studies, which found that pharmacist interventions could sig-
nificantly  improve  medication  adherence  (2–5,8,18,19).  The
project components in these previous studies were not identical to
those in TUPD, however. Some of those interventions provided re-
sources such as a take-home tool kit (4) or blood pressure cuffs for
self-monitoring at home (5,7,8) that our project did not provide.
Our study differed from most other studies in that ours focused
only on rural pharmacies. Although one study did examine rural
Minnesota pharmacies, it was a biennial pharmacy workforce sur-
vey of  outpatient  pharmacies  rather  than an intervention (20).
Also, we did not find any previous study that investigated use of
TUPD materials.
Our results suggest that the pharmacies were able to customize the
project to fit their needs. In addition, our findings indicate that ma-
jor components of the project can be integrated into the usual prac-
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tice of community pharmacies in rural areas. Pharmacies that were
already being reimbursed for medication therapy management or
that synchronized refills may have been more willing to particip-
ate in this project because of their experience in patient consulta-
tions.
This project has several limitations. First, our study did not in-
clude a control group; however, because this was a project evalu-
ation and not a research project, a control group may not have
been needed. Second, pharmacies were not required to collect data
on patients’ blood pressure control. We did not institute this re-
quirement because of limited pharmacist time, lack of adequate
funding, and difficulty in bringing participants in for measure-
ment. Since we did not require pharmacies to collect data on pa-
tients’ blood pressure, we could not conduct additional analyses.
However, some participating pharmacies used a blood pressure
cuff for on-site measurement, and some made the cuff available to
nonparticipating patients. Third, because of the small sample of
pharmacies, the results of our study may not be generalizable to all
pharmacies.  We expect  to  have a  larger  sample size for  study
when additional pharmacies are funded for 2 more years. Fourth,
this project assessed only the perceptions of the pharmacists and
not those of other stakeholders (pharmacy patients or health care
providers).  Lastly,  because of  the annual  funding cycle of  the
CDC grant, we did not investigate long-term medication adher-
ence. Despite these limitations, our project results suggest that
community pharmacies in rural areas can use brief consultations
and TUPD materials to improve blood pressure medication adher-
ence.
The TUPD project could be expanded to other states that have
community pharmacies in rural areas. In year 2, the DPHHS dia-
betes program broadened the TUPD project by conducting a simil-
ar project with 7 of the pilot pharmacies, targeting pharmacy pa-
tients taking blood pressure and diabetes medications. Also, in
2016 the state asthma control  program recruited 2 of the pilot
pharmacies to address asthma medication adherence. This expan-
sion of the TUPD blood pressure approach indicates the willing-
ness of community pharmacies to work on chronic disease man-
agement.  Future  research  should  evaluate  whether  the  TUPD
strategy also improves medication adherence for patients with oth-
er chronic conditions such as diabetes or asthma. In addition, re-
search could assess blood pressure control and medication adher-
ence in community pharmacies in rural areas.
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Table
Table. Characteristics and Services Provided by Community Pharmacies in Rural Areas, by TUPD Funding Status, Montana, 2015–2016a
Characteristic or Service
Pharmacies Funded by TUPD
(n = 25)
Pharmacies Not Funded by TUPD
(n = 95) P Valueb
Pharmacy staff, mean (standard deviation)
No. of pharmacists 2.6 (1.4) 2.6 (1.4) .74
No. of pharmacy technicians 3.4 (2.0) 3.1 (2.0) .64
Pharmacy services and computer-system capabilities, % (no.)
Accept electronic prescriptions from outside health care facilities 100 (25) 95 (90) .24
Automatically refill selected maintenance medication 88 (22) 79 (74) .30
Provide automated refill reminders for hypertension medication 60 (15) 50 (47) .35
Provide prescription synchronizationc 88 (22) 56 (53) .003
Obtain reimbursement for pharmacists for formal medication therapy
managementd from Mirixa or OutcomesMTMe
92 (22) 50 (47) <.001
Pharmacist counseling, % (no.)
Provide consultation services daily 92 (23) 92 (87) .95
   Emphasize importance of following prescribed medication regimen 96 (22) 86 (75) .21
   Assist with medication management and provide feedback to patient’s
physician
100 (23) 81 (70) .02
   Provide comprehensive medication review 56 (14) 69 (61) .21
Abbreviation: TUPD, Team Up. Pressure Down., a program of the Million Hearts initiative (9).
a Data collected through a survey mailed to 259 community pharmacies.
b Calculated by using nonparametric Mann–Whitney U test (mean numbers) or χ2 test (percentages).
c The process of aligning refill dates for all of a patient’s multiple prescriptions.
d Provided by pharmacist to optimize drug therapy and improve health outcomes.
e Two leading medication therapy management vendors in Montana.
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